IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial February 23, 2026 Read More »
IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference May 15, 2026 Read More »
IGC Pharma Advances Caregiver Engagement as Phase 2 CALMA Trial Advances Final Enrollment Phase April 28, 2026 Read More »
